Stromal-derived MAOB promotes prostate cancer growth and progression
Tianjie Pu(Washington State University Spokane), Boyang Jason Wu(Washington State University Spokane), Jingrui Chen(Washington State University Spokane), A Zeng(University of Washington), J. Wang(Washington State University Spokane), Allen C. Gao(UC Davis Comprehensive Cancer Center), Lijuan Yin(Second Military Medical University), Tzu‐Ping Lin(National Yang Ming Chiao Tung University), Jingjing Li(Xuzhou Medical College), Jing Wei(Capital Medical University), Jonathan Melamed(Long Island University), Jinglong Zhang(Washington State University Spokane), Eva Corey(University of Washington)
Cited by 17
Related Papers
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
|Nature Communications|2014|269
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
|European Urology|2017|202
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|138